Autoimmune disorders in patients with T-cell lymphoma: a comprehensive review

References

• Martin DN, Mikhail IS, Landgren O. Autoimmunity and hematologic malignancies: associations and mechanisms. Leuk Lymphoma 2009;50:541-50
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999;10:1419-32
   PubMed Web of Science ®Google Scholar
• Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-85
   PubMed Web of Science ®Google Scholar
• Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 2010;102:83-7
   PubMedGoogle Scholar
• Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002;13:140-9
   PubMed Web of Science ®Google Scholar
• Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol 1992;141:1361-71
   PubMed Web of Science ®Google Scholar
• Rahemtullah A, Longtine JA, Harris NL, et al. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol 2008;32:1593-607
   PubMed Web of Science ®Google Scholar
• Ong ST, Le Beau MM. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma. Semin Oncol 1998;25:447-60
   PubMed Web of Science ®Google Scholar
• Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999;93:3913-21
   PubMed Web of Science ®Google Scholar
• Liang X, Branchford B, Greffe B, et al. Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma. J Pediatr Hematol Oncol 2013;35:e209-13
   PubMedGoogle Scholar
• Sallah S, Gagnon GA. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment. Acta Haematol 1998;99:57-64
   PubMed Web of Science ®Google Scholar
• Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002;99:627-33
   PubMed Web of Science ®Google Scholar
• Zhou Y, Attygalle AD, Chuang SS, et al. Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load. Br J Haematol 2007;138:44-53
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-11
   PubMed Web of Science ®Google Scholar
• Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009;113:3931-7
   PubMed Web of Science ®Google Scholar
• Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501-13
   PubMed Web of Science ®Google Scholar
• Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, et al. Cytotoxic granular protein expression, Epstein–Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 1998;11:754-61
   PubMed Web of Science ®Google Scholar
• Zettl A, Ott G, Makulik A, et al. Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 2002;161:1635-45
   PubMed Web of Science ®Google Scholar
• Gale J, Simmonds PD, Mead GM, et al. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000;18:795-803
   PubMed Web of Science ®Google Scholar
• Howell WM, Leung ST, Jones DB, et al. HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum Immunol 1995;43:29-37
   PubMed Web of Science ®Google Scholar
• Chadburn A, Athan E, Wieczorek R, Knowles DM. Detection and characterization of human T-cell lymphotropic virus type I (HTLV-I) associated T-cell neoplasms in an HTLV-I nonendemic region by polymerase chain reaction. Blood 1991;77:2419-30
   PubMed Web of Science ®Google Scholar
• Roncador G, Garcia JF, Maestre L, et al. FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma. Leukemia 2005;19:2247-53
   PubMed Web of Science ®Google Scholar
• Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011;117:5019-32
   PubMed Web of Science ®Google Scholar
• Francois A, Lesesve JF, Stamatoullas A, et al. Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q. Am J Surg Pathol 1997;21:781-90
   PubMed Web of Science ®Google Scholar
• Kotlyar DS, Osterman MT, Diamond RH, et al. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2011;9:36-41 e31
   PubMed Web of Science ®Google Scholar
• Ross CW, Schnitzer B, Sheldon S, et al. Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol 1994;102:310-15
   PubMed Web of Science ®Google Scholar
• Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003;102:4261-9
   PubMed Web of Science ®Google Scholar
• Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 2008;111:838-45
   PubMed Web of Science ®Google Scholar
• Guitart J, Magro C. Cutaneous T-cell lymphoid dyscrasia: a unifying term for idiopathic chronic dermatoses with persistent T-cell clones. Arch Dermatol 2007;143:921-32
   PubMed Web of Science ®Google Scholar
• Smedby KE, Askling J, Mariette X, Baecklund E. Autoimmune and inflammatory disorders and risk of malignant lymphomas – an update. J Intern Med 2008;264:514-27
   PubMed Web of Science ®Google Scholar
• Dolcetti R, Ponzoni M, Mappa S, Ferreri AJM. Autoimmune disorders and lymphomas. In: Mavragani CP, ed. Autoimmune Disorders – Pathogenetic Aspects: InTech, Rijeka: Croatia. 2011:339-88
   Google Scholar
• Shida S, Takahashi N, Fujishima N, et al. False-positive human immunodeficiency virus antibody test and autoimmune hemolytic anemia in a patient with angioimmunoblastic T-cell lymphoma. Intern Med 2011;50:2383-7
   PubMed Web of Science ®Google Scholar
• Win N, Tiwari D, Keevil VL, et al. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma. Hematology 2007;12:159-62
   PubMed Web of Science ®Google Scholar
• Kato A, Takiuchi Y, Aoki K, et al. Enteropathy-associated T-cell lymphoma type II complicated by autoimmune hemolytic anemia. J Clin Exp Hematop 2011;51:119-23
   PubMedGoogle Scholar
• Wang FX, Zhang XJ, Pan L, et al. [Angioimmunoblastic T-cell lymphoma with autoimmune hemolytic anemia and pure red cell aplasia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007;15:862-5
   PubMedGoogle Scholar
• Oka K, Nagayama R, Yatabe Y, et al. Angioimmunoblastic T-cell lymphoma with autoimmune thrombocytopenia: a report of two cases. Pathol Res Pract 2010;206:270-5
   PubMed Web of Science ®Google Scholar
• Muta T, Yamano Y. Angioimmunoblastic T-cell lymphoma associated with an antibody to human immunodeficiency virus protein. Int J Hematol 2003;78:160-2
   PubMed Web of Science ®Google Scholar
• Motta G, Vianello F, Menin C, et al. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome). Am J Hematol 2002;69:272-6
   PubMed Web of Science ®Google Scholar
• Suehiro S, Shiratsuchi M, Suehiro Y, et al. [Angioimmunoblastic T cell lymphoma (AITL) with autoimmune thrombocytopenia]. Rinsho Ketsueki 2002;43:841-5
   PubMedGoogle Scholar
• Sekiguchi Y, Shimada A, Imai H, et al. CD56+ angioimmunoblastic T-cell lymphoma with Evans syndrome: a case report and review of the literature. J Clin Exp Hematop 2013;53:37-47
   PubMedGoogle Scholar
• Mizobe T, Tsukada J, Higashi T, et al. [Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia]. Rinsho Ketsueki 2005;46:211-16
   PubMedGoogle Scholar
• Hirokawa M, Sawada K, Fujishima N, et al. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol 2009;84:144-8
   PubMed Web of Science ®Google Scholar
• Yi L, Qun S, Wenjie Z, et al. The presenting manifestations of subcutaneous panniculitis-like T-cell lymphoma and T-cell lymphoma and cutaneous gammadelta T-cell lymphoma may mimic those of rheumatic diseases: a report of 11 cases. Clin Rheumatol 2013;32:1169-75
   PubMed Web of Science ®Google Scholar
• Ambrosio MR, Rocca BJ, Ginori A, et al. Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature. Diagn Pathol 2012;7:50
   PubMed Web of Science ®Google Scholar
• Baecklund E, Smedby KE, Sutton LA, et al. Lymphoma development in patients with autoimmune and inflammatory disorders – what are the driving forces? Semin Cancer Biol 2014;24:61-70
   PubMed Web of Science ®Google Scholar
• Tsankova NM, Bevan C, Jobanputra V, et al. Peripheral T-cell lymphoma emerging in a patient with aggressive polymyositis: molecular evidence for neoplastic transformation of an oligoclonal T-cell infiltrate. Acta Neuropathol 2013;126:595-601
   PubMed Web of Science ®Google Scholar
• Pincus LB, LeBoit PE, McCalmont TH, et al. Subcutaneous panniculitis-like T-cell lymphoma with overlapping clinicopathologic features of lupus erythematosus: coexistence of 2 entities? Am J Dermatopathol 2009;31:520-6
   PubMed Web of Science ®Google Scholar
• Suvajdzic N, Stojanovic-Milenkovic R, Tomasevic Z, et al. ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus. Med Oncol 2003;20:409-12
   PubMed Web of Science ®Google Scholar
• Jesus AA, Jacob CM, Silva CA, et al. Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus. Clin Dev Immunol 2011;2011:428703
   PubMed Web of Science ®Google Scholar
• Colleran GC, Cronin KC, Casey M, et al. Enteropathy associated T cell lymphoma: common in coeliac disease. BMJ Case Rep 2009;2009
   Google Scholar
• Marusic M, Gulic S, Gasparov S, et al. Celiac disease and fulminant T lymphoma detected too late in a 35-year-old female patient: case report. Bosn J Basic Med Sci 2011;11:190-3
   PubMed Web of Science ®Google Scholar
• Malamut G, Verkarre V, Callens C, et al. Enteropathy-associated T-cell lymphoma complicating an autoimmune enteropathy. Gastroenterology 2012;142:726-9 e723; quiz e713-24
   PubMed Web of Science ®Google Scholar
• Ye BD. [Inflammatory bowel disease and lymphoproliferative disorders]. Korean J Gastroenterol 2011;58:171-7
   PubMedGoogle Scholar
• Navarro JT, Ribera JM, Mate JL, et al. Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine. Leuk Lymphoma 2003;44:531-3
   PubMed Web of Science ®Google Scholar
• Kanda G, Ryu T, Shirai T, et al. Peripheral T-cell lymphoma that developed during the follow-up of IgG4-related disease. Intern Med 2011;50:155-60
   PubMed Web of Science ®Google Scholar
• Ekstrom Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008;111:4029-38
   PubMed Web of Science ®Google Scholar
• De Saint Paul G, Albes B, Bayle P, et al. [Cutaneous T-cell lymphoma, cutaneous hyperpigmentation and paraneoplastic pemphigus]. Ann Dermatol Venereol 2002;129:896-900
   PubMed Web of Science ®Google Scholar
• Motoi N, Ozawa Y. Malignant T-cell lymphoma of the thyroid gland associated with Hashimoto's thyroiditis. Pathol Int 2005;55:425-30
   PubMed Web of Science ®Google Scholar
• Koida S, Tsukasaki K, Tsuchiya T, et al. Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis. Haematologica 2007;92:e37-40
   Google Scholar
• Yoshida N, Nishikori M, Izumi T, et al. Primary peripheral T-cell lymphoma, not otherwise specified of the thyroid with autoimmune thyroiditis. Br J Haematol 2013;161:214-23
   PubMed Web of Science ®Google Scholar
• Uner AH, Abali H, Engin H, et al. Myasthenia gravis and lymphoblastic lymphoma involving the thymus: a rare association. Leuk Lymphoma 2001;42:527-31
   PubMed Web of Science ®Google Scholar
• Cardinali P, Serrao M, Rossi P, et al. Chronic axonal-demyelinating polyradicular neuropathy associated with mycosis fungoides: a case report. Neurol Sci 2005;26:344-8
   PubMed Web of Science ®Google Scholar
• Hauswirth AW, Skrabs C, Schutzinger C, et al. Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma 2007;48:1139-49
   PubMed Web of Science ®Google Scholar
• Bockle BC, Stanarevic G, Ratzinger G, Sepp NT. Analysis of 303 Ro/SS-A antibody-positive patients: is this antibody a possible marker for malignancy? Br J Dermatol 2012;167:1067-75
   PubMed Web of Science ®Google Scholar
• Sharaiha RZ, Lebwohl B, Reimers L, et al. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973–2008. Cancer 2012;118:3786-92
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Lebwohl B, Rubio-Tapia A, et al. Does celiac disease influence survival in lymphoproliferative malignancy? Eur J Epidemiol 2013;28:475-83
   PubMed Web of Science ®Google Scholar
• Chen L, Yang B, Fan J, et al. Peripheral T-cell lymphoma complicated by immunoglobulin A pemphigus: a case report and literature review. Oncol Lett 2014;8:62-6
   PubMed Web of Science ®Google Scholar
• Maliniemi P, Hahtola S, Ovaska K, et al. Molecular characterization of subcutaneous panniculitis-like T-cell lymphoma reveals upregulation of immunosuppression- and autoimmunity-associated genes. Orphanet J Rare Dis 2014;9:160
   PubMed Web of Science ®Google Scholar
• Kuksin CA, Minter LM. The link between autoimmunity and lymphoma: does NOTCH signaling play a contributing role? Front Oncol 2015;5:51
   Google Scholar
• Wang SS, Vajdic CM, Linet MS, et al. Associations of non-Hodgkin lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. Am J Epidemiol 2015;181:406-21
   PubMed Web of Science ®Google Scholar
• Fallah M, Liu X, Ji J, et al. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol 2014;25:2025-30
   PubMed Web of Science ®Google Scholar
• Goldin LR, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer 2009;124:1497-502
   PubMed Web of Science ®Google Scholar
• Lai Y, Zhang M, Wang L, et al. Uveitis and T cell lymphoma: a rare but notable relationship. Med Oncol 2014;31:992
   PubMed Web of Science ®Google Scholar